Estrologo, Danilo F.
HRN: 21-45-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
CEFTAZIDIME 1GM (VIAL)
01/02/2023
01/22/2023
IVT
1g
Q8
Community Acquired Pneumonia
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes